Trial intelligence / Profile preview

Monofer vs Iron Sucrose Maintenance in CKD-5D

NCT01222884Phase 3Completed

Sponsor
Pharmacosmos
Start
Jun 2011
Primary completion
Oct 2013
Modality
Inorganic Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ferric derisomaltose in anemia of chronic kidney disease (CKD-A), sponsored by Pharmacosmos. Started Jun 2011; status: completed.

02

Drugs

ferric derisomaltose
03

Conditions

anemia of chronic kidney disease (CKD-A)

Beyond the preview

Go deeper on NCT01222884.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01222884.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call